Wei Chan
About Wei Chan
Wei Chan is a Scientist II at Nektar Therapeutics, with a background in Chemical Engineering and Philosophy. He has extensive experience in the field, having previously worked at Sutrovax Inc. and Stanford University.
Current Position at Nektar Therapeutics
Wei Chan currently holds the position of Scientist II at Nektar Therapeutics. He has been with the company since 2018, contributing to various projects and research initiatives in South San Francisco, California. His role involves applying his expertise in chemical engineering and scientific research to advance the company's goals in therapeutic development.
Previous Experience at Nektar Therapeutics
Wei Chan previously worked at Nektar Therapeutics as a Scientist from 2016 to 2017. During this one-year tenure, he was involved in research and development activities that supported the company's mission in the biotechnology sector. His experience at Nektar Therapeutics laid the groundwork for his current role as Scientist II.
Education and Expertise
Wei Chan has an extensive educational background in chemical engineering and philosophy. He earned a Bachelor of Science degree in Chemical Engineering from the Massachusetts Institute of Technology from 2002 to 2006. He further pursued his studies at Stanford University, where he completed a Doctor of Philosophy degree in Chemical Engineering and Philosophy from 2006 to 2013.
Experience at Sutrovax Inc.
Wei Chan worked as a Scientist at Sutrovax Inc. from 2014 to 2016. His two-year experience at the company in Foster City, California, allowed him to apply his scientific knowledge in a practical setting, contributing to the development of innovative solutions in the biotechnology field.
Graduate Studies at Stanford University
Wei Chan was a Graduate Student at Stanford University from 2006 to 2014. During this eight-year period, he engaged in advanced research and coursework, which culminated in his attainment of a Doctorate. His time at Stanford was instrumental in shaping his career in scientific research.